BlueFuse Multi Software

A Seamless, Scalable Software Solution

BlueFuse software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework. It offers a clear, intuitive user interface; a common workflow; and scales for the needs of your lab. This widely implemented software is used in clinical research laboratories globally for research on IVF and preimplantation genetic screening (PGS).

BlueFuse helps labs efficiently and confidently:

  • Run many samples per day with minimal hands-on time
  • Securely store and retrieve sample information and associated reports
  • Create workflow and audit trails to meet lab and local requirements
  • Analyze array-based molecular cytogenetic and IVF data
  • Analyze NGS (next-generation sequencing)-based IVF data
BlueFuse Multi Analysis Software for Molecular Cytogenetics

A powerful software package designed to detect and display areas of potential chromosomal abnormality within the genome.

Read Data Sheet

An Efficient Workflow to Support IVF Research

Screening embryos for aneuploidy prior to transfer has been shown to deliver significant improvements in IVF success (PGS)1.  BlueFuse Multi Software supplies laboratories with a software solution for IVF research. 

Data Visualization for Molecular Cytogenetics

Recent advances in microarray screening technologies have enabled identification of chromosomal microdeletions and microduplications (copy number variation). BlueFuse Multi software is sophisticated multi-user software for analyzing, visualizing, and interpreting results from molecular cytogenetics studies.

Software Availability

BlueFuse is available to users of supported Illumina research products with unlimited licenses per site. It is not available as an open platform to other vendors.

Interested in receiving newsletters, case studies, and information on new applications? Enter your email address.
References
  1. Scott RT Jr, Ferry K, Su J, Tao X, Scott K, et al. (2012) Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril 97(4): 870–875.